Shkreli jury selection expected to take a third day

NEW YORK — Jury selection at the securities fraud trial of a former pharmaceutical CEO notorious for price-gouging hit a rough patch on Tuesday as the court struggled to pick a pool of prospective jurors who could ignore a swirl of bad publicity for the defendant.

A third day of jury selection in Martin Shkreli’s trial was expected on Wednesday with opening statements put off until Thursday morning.

On Tuesday, defence lawyers complained to the judge that news coverage of potential jurors’ negative remarks about him was tainting the process. Under questioning by the judge, one of them had called him “the face of corporate greed,” a reference to his reputation for raising the price of a life-saving drug by 5,000 per cent and making no apologies about it.

The judge denied defence requests to start the selection over and ban reporters from listening in on sidebars. She agreed to re-question about 40 people who had already qualified for the pool as a precaution.